Related Experiment Video
Updated: Mar 8, 2026
High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
SPECT and PET in ischemic heart failure
George Angelidis1, Gregory Giamouzis2, Georgios Karagiannis3
1Department of Nuclear Medicine, Larissa University Hospital, Larissa, Greece.
Insights
Nuclear cardiology techniques like SPECT and PET are crucial for diagnosing and managing ischemic heart failure. This review explores their advances and controversies in patient evaluation and treatment guidance.
Area of Science:
- Cardiovascular Imaging
- Nuclear Cardiology
- Heart Failure Diagnostics
Background:
- Heart failure is a widespread clinical syndrome with substantial global morbidity and mortality.
- Ischemic heart disease is the primary cause of heart failure in industrialized nations.
- Accurate diagnosis and management necessitate detailed anatomical and functional information via imaging.
Purpose of the Study:
- To review the role of nuclear cardiology, specifically SPECT and PET, in evaluating ischemic heart failure.
- To address controversies surrounding SPECT and PET guided therapy.
- To present technological advancements enhancing nuclear cardiology's utility in heart failure investigation.
Main Methods:
- Myocardial single-photon emission computed tomography (SPECT) using thallium-201 or technetium-99m tracers.
- Positron emission tomography (PET) for myocardial perfusion, metabolism, and viability assessment.
- Analysis of reported variations in sensitivity and specificity among imaging modalities.
Main Results:
- SPECT provides valuable data on ventricular function, perfusion, viability, and synchronism.
- PET enables quantitative analysis and high-quality imaging of perfusion, metabolism, and viability.
- Different techniques assess distinct cardiac parameters, leading to varied diagnostic performance.
Conclusions:
- Nuclear cardiology modalities (SPECT and PET) are integral to assessing ischemic heart failure.
- Ongoing technological innovations are poised to further solidify their role in patient investigation.
- Further research is needed to resolve controversies regarding SPECT and PET guided therapy.
Abstract:
Heart failure is a common clinical syndrome associated with significant morbidity and mortality worldwide. Ischemic heart disease is the leading cause of heart failure, at least in the industrialized countries. Proper diagnosis of the syndrome and management of patients with heart failure require anatomical and functional information obtained through various imaging modalities. Nuclear cardiology techniques play a main role in the evaluation of heart failure. Myocardial single photon emission computed tomography (SPECT) with thallium-201 or technetium-99 m labelled tracers offer valuable data regarding ventricular function, myocardial perfusion, viability, and intraventricular synchronism. Moreover, positron emission tomography (PET) permits accurate evaluation of myocardial perfusion, metabolism, and viability, providing high-quality images and the ability of quantitative analysis. As these imaging techniques assess different parameters of cardiac structure and function, variations of sensitivity and specificity have been reported among them. In addition, the role of SPECT and PET guided therapy remains controversial. In this comprehensive review, we address these controversies and report the advances in patient's investigation with SPECT and PET in ischemic heart failure. Furthermore, we present the innovations in technology that are expected to strengthen the role of nuclear cardiology modalities in the investigation of heart failure.
